Skip to main content
. 2022 Sep 27;2022(9):CD014638. doi: 10.1002/14651858.CD014638.pub2
Date Event Description
7 May 2021 New citation required and conclusions have changed Summary of most important changes when compared to second update:
The original review was split and this part now focuses on dexrazoxane only. We analysed adult and paediatric data separately. New randomised controlled trials and additional data on some already included studies were added. We updated the risk of bias criteria. In previous versions of the review, best‐case analyses were performed; starting with this update we present results from available‐case, best‐case and worst‐case analyses where possible.
7 May 2021 New search has been performed The search for eligible studies was updated to 7 May 2021.